News – Page 438 – Endpoints News

Basilea’s cancer pipeline slimdown continues; Aquestive looks to outlicense seizure drug in US

3 years ago

Rigel churns out another late-stage clinical failure — this time in Covid-19

3 years ago

An NK cell therapy biotech pulls IPO ambitions weeks after second trial clearance

3 years ago

CSL stacks up $4.5B in chips — with a $200M ante — to wager on the next-gen mRNA wave

3 years ago

ICER says it's fair for BioMarin and CSL to price incoming hemophilia gene therapies at $2M-$3M

3 years ago

Updated: GSK nabs priority review on RSV vaccine, kicks off showdown with Pfizer — while 'setting the bar high' on ...

3 years ago

CFIUS review triggers delay on F-star's sale to Chinese player

3 years ago

Leading a $60M launch round, RA Capital backs another 'toad venom' startup

3 years ago

Exelixis shells out $100M cash in a pair of deals, shooting for different takes on CD47, ADCs

3 years ago

Amid revenue dip, Pfizer CEO Albert Bourla is focused on 'what's next'

3 years ago

FDA warns Amazon again for selling unapproved drugs online

3 years ago

New JAMA study digs into the rise of stacking FDA’s expedited programs and designations for new drugs

3 years ago

Eli Lilly plans to make tirzepatide next big thing as pharma experiences 'unprecedented' demand for the drug

3 years ago

FDA clarifies when sponsors' expanded access policies need to be made public

3 years ago

#CPHI22: As Samsung’s new plant comes online, it looks to expand in Korea and beyond

3 years ago

HHS renews 'call to action' with Covid booster ad spots

3 years ago

College athlete deals and pharma? Dexcom tests the waters in a first move that opens new spokesperson doors for ...

3 years ago

MarketingRx roundup: Moderna clues in to ‘Jeopardy’; BMS, Gilead build out clinical trial diversity program

3 years ago

Betting on CD47 as others ditch the target, ALX borrows up to $100M to push sole clinical drug forward

3 years ago

Covid-19 continues to befuddle Big Pharma as AbbVie axes PhI of an oral drug

3 years ago

Updated: Samsara backs ex-Gilead duo's amalgamation of NASH, liver drug assets from former employer, other biopharmas

3 years ago

Updated: Eli Lilly blames Biden's IRA for cancer drug discontinuation as the new pharma playbook takes shape

3 years ago

JP Morgan splashes into the life sciences, tapping Stephen Squinto to run venture team with high-powered advisors

3 years ago

Covid-19 spurred a historic vaccine R&D effort. What does it mean for future pandemics?

3 years ago

First page Previous page 435 436 437438439 440 441 Next page Last page